Allergic Contact Dermatitis to Superglue

January 2013 in “ International Journal of Trichology ”

L Sornakumar, C Shanmugasekar, Reena Rai, S. Shanmuga Priya

allergic contact dermatitis superglue 2-hydroxyethyl methacrylate androgenic alopecia topical steroids contact dermatitis glue alopecia steroids

Studysummary This case report highlights a rare allergic reaction to 2-hydroxy ethyl meta acrylate, found in superglue, in a man who developed skin lesions from wearing a wig.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on journals.lww.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

63 upvotes 2 years ago

Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

community Got prescribed clobetasol propionate 0.05%

5 upvotes 1 week ago

The user is experiencing diffuse thinning and receded hairline, using dutasteride, minoxidil, and ketoconazole without regrowth, and was prescribed clobetasol propionate 0.05% with salicylic acid for possible inflammation. Other users caution against using the strong steroid without a serious condition, sharing experiences of adverse effects and alternative treatments for scalp issues.

community AH-001 another topical AR degrader beside GT20029, completed Phase I

8 upvotes 10 months ago

AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.

community can someone help me identify these pls

in Treatment 10 months ago

The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

community DHT Harms Scalp Microbiome: DHT Itch is REAL

413 upvotes 1 year ago

Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

community Is there a topical androgen receptor blocker so we don't have to fuck with the enzyme and destroy our allopregnanolone, but go and hit the end target straight?

in Treatment 44 upvotes 2 years ago

The conversation discusses topical androgen receptor blockers for hair loss, mentioning Clascoterone, Pyrilutamide, GT20029, and RU58841. Ketoconazole's effectiveness and application methods are also debated.

Related Research

3 / 3 results

research Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5%

3 citations , January 2018

This study reports a case of pustular allergic contact dermatitis following the use of 5% minoxidil solution in a female patient, highlighting an uncommon reaction to a frequently used dermatological treatment.

research An Unusual Case of Contact Dermatitis

5 citations , January 2017 in “Skin appendage disorders”

In this case report, the authors linked acute psoriasiform contact dermatitis of the forehead and scalp to a low-laser light cap, identifying DMDE in the fabric as a likely cause.

research Ambiguous Alopecia in a 36-Year-Old Woman

October 2012

This article presents a dermatological case involving a 36-year-old woman with ambiguous alopecia, evaluated using videodermatoscopy, but it reports no new research findings or clinical outcomes.